Health Care: Drugs

Agenus Inc (AGEN: NASDAQ)

$3.15 -0.02 | -0.63%
08/28/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 3.05M 15.96M 2.76M 3.36M
Cost of Sales 536.12K 671.97K 0.00 122.95K
Gross Operating Profit 2.51M 15.29M 2.76M 3.24M
Selling, General, and Administrative Expenses 14.48M 11.47M 10.82M 12.11M
Research & Development 13.01M 10.56M 11.02M 12.88M
Operating Income before D & A (EBITDA) -24.98M -6.74M -19.09M -21.75M
Depreciation & Amortization 586.34K 1.62M 2.25M 3.44M
Interest Income 7.93K 23.34K 18.79K 37.56K
Other Income - Net -2.67M 110.47K 1.94K 4.68M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -28.23M -8.23M -21.32M -20.47M
Interest Expense 2.43M 4.72M 4.21M 4.87M
Pre-Tax Income -30.66M -12.95M -25.53M -25.34M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -30.07M -11.32M -23.28M -21.91M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -30.07M -11.32M -23.28M -21.91M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -30.07M -11.32M -23.28M -21.91M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-30.07M -11.32M -23.28M -21.91M
Preferred Dividends
Net Income Available To Common -33.23M -12.12M -24.07M -22.70M
Basic EPS from Continuing Ops. -1.12 -0.48 -1.17 -1.36
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.12 -0.48 -1.17 -1.36
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 -0.03 -0.04 -0.02
Basic EPS, Total -1.12 -0.51 -1.21 -1.38
Basic Normalized Net Income/Share -1.12 -0.48 -1.17 -1.36
EPS fr Continuing Ops. -1.12 -0.48 -1.17 -1.36
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.12 -0.48 -1.17 -1.36
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 -0.03 -0.04 -0.02
EPS, Total -1.12 -0.51 -1.21 -1.38
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.12 -0.48 -1.17 -1.36
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AGEN

Latest AGEN Headlines from TheStreet

More Financial News for AGEN

Press Releases for AGEN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter